Ongoing Clinical Projects: the RUBY and Prevena Studies


RUBY Study

Reducing the Burden of Breast Cancer in Young Women

Breast Cancer Cells
Photo by Ed Uthman/Creative Commons


The RUBY Study is a pan-Canadian collaborative comprised of a national network of 62 researchers and clinicians at 44 institutions and clinics across Canada, with the common goal of studying breast cancer in young women. Currently under the direction of Dr. Steven Narod (Principal-Investigator, Women’s College Hospital) and Dr. May Lynn Quan (Co-Principal Investigator, University of Calgary), the overall aim of this program is to establish a population-based cohort of 1,200 women newly-diagnosed with breast cancer aged 40 and under. Funded by a joint funding initiative through the Canadian Breast Cancer Foundation (CBCF) and the Canadian Institutes of Health Research (CIHR), this study cohort will support four synergistic sub-projects in order to enable the research team to comprehensively and holistically address major concerns for young women facing breast cancer.


The RUBY Program focuses on research designed to have practical consequences by assisting patients, family and healthcare professionals to develop and select the tools that will enable optimal care for young women with breast cancer and their families.

I am a Co-Principal Investigator for RUBY in Saskatchewan along with Dr. Pamela Meiers of the Les and Irene Dube Breast Centre of Care in Saskatoon.


The Prevena Study

A randomized control trial exploring the ability of Negative Pressure Wound Therapy (NWPT) to reduce Colorectal Surgical Site Infections (SSI).

Principal Investigator: Dr. Gary Groot

Lead Sponsor: University of Saskatchewan


Kinetic Concepts Inc.

Saskatoon Health Region

The study explores the ability of negative pressure wound therapy (Prevena dressing) to reduce post operative superficial surgical site infection rate in elective colorectal surgery. Half of the participants will receive Prevena dressing on closed incision immediately after the operation while the other half will receive conventional surgical dressing.